Refractory Sarcoma
Showing 1 - 25 of 9,995
Ewing Sarcoma Trial in Warsaw (Naxitamab)
Not yet recruiting
- Ewing Sarcoma
-
Warsaw, Mazowian, PolandMother and Child Institute
Jul 28, 2023
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)
Not yet recruiting
- Refractory Ewing Sarcoma
- +2 more
- (no location specified)
Feb 15, 2023
Refractory HIV Associated Kaposi Sarcoma Trial (Dostarlimab in Combination Antiretroviral Therapy)
Not yet recruiting
- Refractory HIV Associated Kaposi Sarcoma
- Dostarlimab in Combination Antiretroviral Therapy
- (no location specified)
Dec 2, 2022
Kaposi Sarcoma, Classic Kaposi Sarcoma, Refractory Kaposi Sarcoma Trial (Pembrolizumab + Lenvatinib)
Not yet recruiting
- Kaposi Sarcoma
- +2 more
- Pembrolizumab + Lenvatinib
- (no location specified)
Apr 27, 2023
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Sarcoma Trial in Guangzhou (chidamide and toripalimab)
Recruiting
- Sarcoma
- chidamide and toripalimab
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 4, 2022
Malignant Abdominal Tumor, Malignant Pelvic Tumor, Recurrent Colon Carcinoma Trial in Rochester (Cisplatin, Cytoreductive
Recruiting
- Malignant Abdominal Neoplasm
- +26 more
- Cisplatin
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- +2 more
- CPI 613
- +3 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
May 10, 2023
Pediatric Sarcoma, Refractory, Pediatric Sarcoma, Relapsed Trial in Tampa, Columbus (GEM/DOX + TGFBi expanded NK cells)
Recruiting
- Pediatric Sarcoma, Refractory
- Pediatric Sarcoma, Relapsed
- GEM/DOX + TGFBi expanded NK cells
-
Tampa, Florida
- +1 more
Jan 3, 2023
Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)
Active, not recruiting
- Refractory Soft Tissue Sarcomas
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Sarcoma Trial in Seoul (Pemetrexed, cisplatin)
Active, not recruiting
- Sarcoma
- Pemetrexed, cisplatin
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
May 30, 2022
Sarcoma, Ewing Trial in China (TK216+Vincristin)
Not yet recruiting
- Sarcoma, Ewing
- TK216+Vincristin
-
Beijing, Beijing, China
- +7 more
Jul 25, 2022
Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)
Recruiting
- Ewing Sarcoma
- Ewing-Like Sarcoma
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 18, 2022
Sarcoma, Clear Cell Trial in United States (CPI-613 + Hydroxychloroquine)
Recruiting
- Sarcoma, Clear Cell
- CPI-613 + Hydroxychloroquine
-
Duarte, California
- +7 more
Nov 10, 2022
Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)
Not yet recruiting
- Sarcoma, Ewing
- Rhabdomyosarcoma
- PEN-866
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Osteosarcoma, Ewing Sarcoma of Bone Trial in Warsaw (Regorafenib)
Recruiting
- Osteosarcoma
- Ewing Sarcoma of Bone
-
Warsaw, Mazovian, PolandMother and Child Institute
Sep 7, 2022
Sarcoma Trial in Shanghai (Apatinib monotherapy)
Recruiting
- Sarcoma
- Apatinib monotherapy
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
May 18, 2022
Pathologically Confirmed Cancer Refractory to Conventional Therapy, Refractory Cancer, Metastatic Cancer Trial in Santa Monica
Not yet recruiting
- Pathologically Confirmed Cancer Refractory to Conventional Therapy
- +7 more
- SNK02
-
Santa Monica, CaliforniaSarcoma Oncology Center
Aug 10, 2023
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Recruiting
- Recurrent Childhood Acute Myeloid Leukemia
- +17 more
-
Miami, FloridaNicklaus Children's Hospital
May 13, 2023
Tumor, Desmoplastic Small Round Cell, Adult, Tumor, Desmoplastic Small Round Cell, Childhood, Sarcoma, Ewing Trial in Spain (nab
Completed
- Tumor, Desmoplastic Small Round Cell, Adult
- +4 more
- nab paclitaxel
-
Barcelona, Spain
- +6 more
Jun 6, 2022